InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by McAvoy David R., Conseiller Juridique et Directeur de la Conformité. Officer active across 4 companies, notably Brickell Biotech, Inc.. In total, 5 filings have been recorded. Split: 3 buys · 0 sell. Total volume traded: €41k. Activity tracked since 17 May 2021. The latest transaction was filed on 5 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McAvoy David R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,113 shares@ US$18.8572100.0% of flowOrdinary SharesSEC:0000950170-25-113800:0
Canonical exit: 4 Dec 2025 (T+90)
16,741 sharesOrdinary SharesSEC:0000950170-25-034670:0
20,000 sharesCommon StockSEC:0001628280-23-033914:0
18,124 shares@ US$0.669745.7% of flowCommon StockSEC:0000819050-21-000124:0
Canonical exit: 21 Oct 2021 (T+90)
18,622 shares@ US$0.8054.3% of flowCommon StockSEC:0001062993-21-004867:0
Canonical exit: 15 Aug 2021 (T+90)
5 of 5 declarations
About McAvoy David R.
David R. McAvoy is General Counsel and Chief Compliance Officer at Brickell Biotech, Inc., a company specializing in the development of biopharmaceutical therapies. In this role, he is responsible for legal and compliance matters, ensuring that the company adheres to applicable regulations.
